+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Remicade"

From
Entyvio - Product Thumbnail Image

Entyvio

  • Report
  • August 2018
  • 37 Pages
  • Global
From
Axial spondyloarthritis (axSpA) Market and Forecast Analysis to 2037 - Product Thumbnail Image

Axial spondyloarthritis (axSpA) Market and Forecast Analysis to 2037

  • Drug Pipelines
  • July 2018
  • 393 Pages
  • Global
From
Simponi - Product Thumbnail Image

Simponi

  • Report
  • May 2018
  • 55 Pages
  • Global
From
From
From
Crohn's Disease - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Crohn's Disease - Global Drug Forecast and Market Analysis to 2029

  • Report
  • September 2020
  • 148 Pages
  • Global
From
From
Psoriatic Arthritis: Competitive Landscape to 2026 - Product Thumbnail Image

Psoriatic Arthritis: Competitive Landscape to 2026

  • Report
  • December 2018
  • 48 Pages
  • Global
From
Market Spotlight: Psoriatic Arthritis - Product Thumbnail Image

Market Spotlight: Psoriatic Arthritis

  • Report
  • September 2020
  • 65 Pages
  • Global
Crohn's Disease Forecast and Market Analysis to 2026 - Product Thumbnail Image

Crohn's Disease Forecast and Market Analysis to 2026

  • Report
  • August 2018
  • 679 Pages
  • Global
From
Crohn's Disease: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Crohn's Disease: Dynamic Market Forecast to 2026

  • Report
  • October 2018
  • 50 Pages
  • Global
From
Digital Landscape: Ankylosing Spondylitis - Product Thumbnail Image

Digital Landscape: Ankylosing Spondylitis

  • Report
  • September 2018
  • 132 Pages
  • Global
From
From
Loading Indicator

Remicade is a biologic drug used to treat immune disorders such as Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis. It is a monoclonal antibody that works by blocking the action of tumor necrosis factor (TNF), a protein that plays a role in inflammation. Remicade is administered intravenously and is usually given in a series of three infusions over a period of several weeks. Remicade is a major player in the immune disorders drugs market, with a wide range of indications and a long track record of safety and efficacy. It is one of the most widely prescribed biologic drugs in the world, and is used by millions of patients. Companies in the Remicade market include Johnson & Johnson, Merck, Pfizer, AbbVie, and Amgen. Show Less Read more